Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-14 of 14
Keywords: Tetrahydrocannabinol
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Alonso Cortez-Resendiz, Timothy J. Leiter, Steven M. Riela, Nicholas M. Graziane, Wesley M. Raup-Konsavage, Kent E. Vrana
Journal:
Medical Cannabis and Cannabinoids
Med Cannabis Cannabinoids (2025) 8 (1): 31–46.
Published Online: 05 February 2025
... is the use of cannabis to reduce/treat chronic pain disorders based on anecdotal accounts and the function of its phytocannabinoids. The two main cannabinoids in cannabis, tetrahydrocannabinol (THC) and cannabidiol, act on CB1 and CB2 receptors (in addition to several additional receptors). It is through...
Journal Articles
Journal:
Medical Cannabis and Cannabinoids
Med Cannabis Cannabinoids (2024) 7 (1): 149–159.
Published Online: 28 August 2024
... agonists such as nabilone and tetrahydrocannabinol (THC) may alleviate PTSD symptoms. We investigated the safety and effectiveness of THC-predominant cannabis flowers for inhalation to manage PTSD symptoms in a real-world setting. Methods: We analysed data from the UK patient registry, T21. Validated...
Journal Articles
Journal:
Medical Cannabis and Cannabinoids
Med Cannabis Cannabinoids (2024) 7 (1): 119–124.
Published Online: 17 July 2024
... and April 2, 2023. Methods: The Lion Poll omnibus survey asked questions of adult-aged Pennsylvanians to assess awareness of cannabidiol (CBD) and products containing tetrahydrocannabinol (THC), including marijuana, the likelihood of reporting cannabinoid use to health care providers (HCPs), and perceptions...
Journal Articles
Subject Area:
High Impact Articles in Pharmacology
,
General Medicine
,
Pharmacology
,
Public Health
Journal:
Medical Cannabis and Cannabinoids
Med Cannabis Cannabinoids (2024) 7 (1): 59–67.
Published Online: 14 March 2024
...Knud Gastmeier; Anne Gastmeier; Frank Schwab; Thomas Herdegen Introduction: Tetrahydrocannabinol (THC) is often prescribed for ambulatory palliative patients to improve sleep quality and appetite and to reduce anxiety, stress, and pain. However, it is not known if THC has also an effect...
Journal Articles
Subject Area:
High Impact Articles in Pharmacology
,
General Medicine
,
Pharmacology
,
Public Health
Journal:
Medical Cannabis and Cannabinoids
Med Cannabis Cannabinoids (2024) 7 (1): 19–30.
Published Online: 23 February 2024
...], [anxiolytic], [PTSD], [OCD], [GAD], [cannabis], [marijuana], [tetrahydrocannabinol], [THC]. Results: While several case-control and cohort studies have reported no correlation between CU/CUD and AD or state anxiety ( N = 5), other cross-sectional, and longitudinal studies report significant relationships ( N...
Journal Articles
Journal:
Medical Cannabis and Cannabinoids
Med Cannabis Cannabinoids (2023) 6 (1): 41–45.
Published Online: 26 April 2023
... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2023 Cannabis Marijuana Cannabidiol Tetrahydrocannabinol Chronic pain Dosing Key Points The lack of clinical data and dosing recommendations for medical cannabis...
Journal Articles
Journal:
Medical Cannabis and Cannabinoids
Med Cannabis Cannabinoids (2023) 6 (1): 8–14.
Published Online: 30 January 2023
... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2023 Cannabis Marijuana Cannabidiol Tetrahydrocannabinol Driving Impairment Driving under the influence of cannabis has been identified as a public health...
Journal Articles
Subject Area:
Topic Article Package: ADC (Antibody-Drug Conjugates)
,
General Medicine
,
Pharmacology
,
Public Health
Paul T. Kocis, Samuel Wadrose, Ryan Lee Wakefield, Aqib Ahmed, Renata Calle, Rohan Gajjar, Kent E. Vrana
Journal:
Medical Cannabis and Cannabinoids
Med Cannabis Cannabinoids (2023) 6 (1): 1–7.
Published Online: 12 January 2023
... to evaluate potential cannabinoid drug-drug interactions with other medications. The CANNabinoid Drug Interaction Review (CANN-DIR™) is a free web-based platform that has been developed to screen for potential drug-drug interactions from the perspective of how a cannabinoid delta-9-tetrahydrocannabinol (THC...
Journal Articles
Xiaoxue Li, Jegason P. Diviant, Sarah S. Stith, Franco Brockelman, Keenan Keeling, Branden Hall, Jacob M. Vigil
Journal:
Medical Cannabis and Cannabinoids
Med Cannabis Cannabinoids (2022) 5 (1): 76–84.
Published Online: 13 April 2022
... (“ C. indica ,” “ C. sativa ,” or “hybrid”) did not differ in symptom relief, people that used joints to combust the flower reported greater symptom relief than pipe or vaporizer users. Across cannabinoid levels, tetrahydrocannabinol, and cannabidiol levels were generally not associated with changes...
Journal Articles
Journal:
Medical Cannabis and Cannabinoids
Med Cannabis Cannabinoids (2022) 5 (1): 32–35.
Published Online: 25 February 2022
... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. COVID-19 SARS-CoV-2 Cannabis and COVID-19 Cannabinoids and COVID-19 Medical cannabis Medical marijuana Cannabidiol Cannabidiol Tetrahydrocannabinol Drug repurposing...
Journal Articles
Journal:
Medical Cannabis and Cannabinoids
Med Cannabis Cannabinoids (2021) 4 (2): 121–124.
Published Online: 17 June 2021
... adverse drug events and drug-drug interactions with medical and consumer cannabidiol (CBD) use . J Clin Med . 2019 ; 8 : 989 . 10.3390/jcm8070989 . 14. Brown JD . Potential adverse drug events with tetrahydrocannabinol (THC) due to drug-drug interactions . J Clin Med . 2020 ; 9...
Journal Articles
Journal:
Medical Cannabis and Cannabinoids
Med Cannabis Cannabinoids (2020) 3 (1): 61–73.
Published Online: 07 July 2020
... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Tetrahydrocannabinol Cannabidiol Drug-drug interactions Cytochrome...
Journal Articles
Journal:
Medical Cannabis and Cannabinoids
Med Cannabis Cannabinoids (2019) 2 (1): 1–13.
Published Online: 25 February 2019
... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Cannabis sativa Medicinal cannabis Cannabidiol Tetrahydrocannabinol Quantitative analysis Mass spectrometry...
Journal Articles
Journal:
Medical Cannabis and Cannabinoids
Med Cannabis Cannabinoids (2019) 2 (1): 60–64.
Published Online: 25 January 2019
...Natalia Szejko; Ewgeni Jakubovski; Carolin Fremer; Kirsten R. Müller-Vahl We present the case of a 12-year-old boy diagnosed with Tourette syndrome, who was successfully treated with a combination of vaporized medicinal cannabis and oral pure tetrahydrocannabinol (THC). Due to severe motor tics...